Merkel cell carcinoma causes investigated

June 17, 2014 by Anika Rodgers
The Merkel cell polyomavirus is likely less important to MCC causation in regions with high UV exposure, like in WA. Credit: Michael Spencer

Local researchers are decoding the secrets to a rare and aggressive form of skin cancer that is prevalent in Western Australia.

PathWest and the University of Western Australia (UWA) are using immunohistochemistry to better understand the biology and causation of Merkel cell carcinoma (MCC).

UWA clinical Associate Professor, Benjamin Wood says West Australians are more likely to develop this deadly cancer.

"Western Australia has one of the highest rates of Merkel cell carcinoma in the world," Dr Wood says.

"It's roughly two to three times greater than the rates reported from other places around the world.

"Generally when people think of skin cancer they think of melanoma and non-melanoma skin cancers. Merkel cell carcinoma is one of the non-melanoma skin cancers and it's extremely dangerous.

"The mortality rate of MCC is twice that of invasive melanomas."

However, Dr Wood says MCC still relatively uncommon compared to other types of skin cancers.

Two causes of Merkel cell carcinoma studied

In addition to sun exposure, a virus is important in causing many cases of MCC. In 2008, a previously unknown virus, named Merkel cell polyomavirus (MPyV), was discovered.

"MPyV has been found to be causing this tumour [MCC] in a significant number of patients, but we don't really understand exactly how this viral infection interacts with , or what is happening in people who apparently don't have the virus," Dr Wood says.

Ninety-five patients with primary MCC from Western Australia took part in the research between 2011 and 2012, and they were predominately males over 60 years of age.

"We studied samples from each of these patients for immunohistochemical evidence of MPyV and for evidence of chronic sun damage, including changes to the connective tissue and epidermis."

"We found that Merkel cell polyomavirus positivity by immunohistochemistry was much less frequent in the cases occurring on sun-damaged skin when compared with cases on non sun-damaged skin."

"One of the things we know about Merkel cell carcinoma is that a big risk factor to getting it is when the body becomes immunosuppressed," Dr Wood says.

From the research, the researchers found MCC might in fact be two or more different types of tumours.

"MPyV might be less important in a type of MCC which is more frequent in regions with high rates of UV exposure and high rates of MCC, such as Western Australia."

Dr Wood says they are doing further research to look at whether there are other biological differences between MCC in sun-damaged and non sun-damaged skin.

Explore further: Cancer researchers find key oncoprotein in Merkel cell carcinoma

More information: "Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome." Dabner M, McClure RJ, Harvey NT, Budgeon CA, Beer TW, Amanuel B, Wood BA. Pathology. 2014 Apr;46(3):205-10. DOI: 10.1097/PAT.0000000000000069

Related Stories

Cancer researchers find key oncoprotein in Merkel cell carcinoma

August 15, 2011
Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform healthy cells into a rare but deadly skin cancer called Merkel ...

Study finds radiation best treatment for a rare skin cancer

May 7, 2014
Radiation treatment can help reduce the recurrence of Merkel cell carcinoma, a rare and aggressive skin cancer, while chemotherapy does not appear to have any impact on recurrence or survival, according to a Kaiser Permanente ...

PET more sensitive than CT for merkel cell carcinoma

May 15, 2012
(HealthDay) -- Fluorine-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) is significantly more sensitive and equally specific compared with traditional computed tomography (CT) imaging for evaluation of ...

Researchers use genomics to identify a molecular-based treatment for a viral skin cancer

May 9, 2012
Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecule activated by this virus ...

National AOA Research Fellowship will help shine light on skin cancer

May 21, 2014
The same enzyme that enables us to walk in the sun without shedding our skin can also enable non-melanoma skin cancer to survive and grow, researchers say.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.